Pharmaceutical

CorMedix announced its chief scientific officer Dr. Antony Pfaffle will present at an upcoming biotech conference.

CorMedix (NYSE:CRMD) announced its chief scientific officer Dr. Antony Pfaffle will present at an upcoming biotech conference.
As quoted in the press release:

Dr. Pfaffle will participate on a panel titled, ”Regulatory Challenges: Expanding Endpoints,” along with Arsanis’ Chief Development Officer, David Mantus, and moderated by Chief Executive Officer of Scynexis, Marco Taglietti. The panel is scheduled for 11:30 a.m. – 12:00 p.m. ET on Tuesday, September 19, 2017.

Click here to read the full press release.

Source: www.accesswire.com

MARKETS

Markets
TSX19505.33-187.59
TSXV654.76+8.72
DOW32396.17-402.23
S&P 5004091.19-27.44
NASD12348.76-20.22
ASX6998.10+5.10

COMMODITIES

Commodities
Gold1764.70+8.36
Silver19.90+0.04
Copper3.49-0.03
Palladium2062.12+8.12
Platinum897.90+5.91
Oil93.36-1.06
Heating Oil3.37-0.01
Natural Gas7.77+0.06

DOWNLOAD FREE REPORTS

×